Preeclampsia, a complex condition during pregnancy, affects about one in ten pregnancies, characterized by a sudden rise in blood pressure and potential kidney issues.
Researchers at the Medical College of Wisconsin (MCW) have made significant strides in understanding this condition, offering hope for better management and treatment strategies.
This condition typically arises after 20 weeks of pregnancy in women who have had normal blood pressure.
Preeclampsia can lead to severe complications for both the mother and the fetus, including organ damage.
Currently, there’s no cure, and treatments mainly focus on managing blood pressure to ensure the safest possible delivery. Severe cases often require pre-term deliveries.
Dr. Jennifer McIntosh, an associate professor at MCW, explains that preeclampsia’s impact varies. While some patients experience it as a temporary issue, others face life-altering challenges, including prolonged hospital stays and intensive care for the newborn.
The MCW Study
The MCW study, published in Science Advances, investigated the syncytiotrophoblast (STB) layer of cells in the placenta. This layer acts as a barrier, preventing the mother’s immune system from attacking the fetus and vice versa.
The researchers explored the hypothesis that stress on the STB layer could damage the placenta and lead to preeclampsia.
Key Findings
- The study analyzed placentas donated for research, comparing those from normal pregnancies with those affected by preeclampsia. They observed higher levels of cellular stress in the STB layer in placentas from preeclamptic pregnancies.
- Researchers identified overactive signaling of the Gαq protein, linked to hormonal imbalances in preeclampsia.
- A new mouse model was developed to mimic these conditions, confirming that activating specific signaling pathways can induce preeclampsia-like symptoms.
Potential for Future Treatment
The study also tested a drug known as MitoQ, which reduces mitochondrial stress. This drug showed promise in protecting against preeclampsia symptoms, paving the way for potential clinical trials.
Dr. Justin Grobe, co-corresponding author, highlights the importance of this model in understanding how various factors contribute to preeclampsia throughout pregnancy. It allows for precise testing of specific signals at different pregnancy stages.
Dr. McIntosh emphasizes the urgency of understanding preeclampsia to develop effective cures. The MCW team is optimistic about future research, with plans for clinical pilot studies to explore the efficacy of potential treatments like MitoQ.
If you care about blood pressure, please read studies that black licorice could cause dangerous high blood pressure, and this common plant nutrient could help reduce high blood pressure.
For more information about blood pressure, please see recent studies about how coffee influence your risk of high blood pressure, and results showing this olive oil could reduce blood pressure in healthy people.
The research findings can be found in Science Advances.
Copyright © 2023 Knowridge Science Report. All rights reserved.
